Search

You searched for "medication"

2958 results found

Mobile technologies to support global ear and hearing care

4 May 2021 | | ENTA - Audiology - Adult, ENTA - Otology
By combining mobile technology with artificial intelligence, more people can access ear and hearing care. The World Health Organization (WHO) estimates that worldwide, nearly half a billion people have moderate or worse hearing loss [1]. The vast majority of people...

Monitoring the mouth in ALS

1 January 2019 | | Articulatory assessment, alternating motion rate, amyotrophic lateral sclerosis, bulbar motor involvement, speech movement analysis
Amyotrophic lateral sclerosis (ALS; or motor neurone disease) is characterised by gradual loss of function in the speech muscles resulting in a progressive deterioration in a person’s ability to communicate. The aim of this study was to investigate the use...

BLA Position Statement - Interview with Mark Watson

1 October 2019
Author and interviewer: Stefan Linton, ENT Registrar, Manchester Royal Infirmary. We caught up with Mark Watson, President of the British Laryngology Association, to find out his thoughts on the BLA’s position statement on the use of Gardasil vaccination in the...

Dupilumab prospective RCT for CRSwNP, a multinational trial of 60 patients with a 16-week CT follow-up

7 January 2021 | | ENTA - Rhinology / Sinus
This transcontinental work describes a randomised, double blind, placebo controlled parallel group study over a 16-week period, assessing 60 patients with CRSwNP by CT scan scores. All patients had a four-week period of intranasal corticosteroids followed by randomisation to add...

Step change in care – changing the quality of life and supporting the NHS

31 October 2023 | Company Profiles, Research & Development
Up to 500,000 GP appointments could be saved per annum with patient self-referral to audiology practices - easing pressure on the NHS, according to a new report.

UK clinics providing Lenire tinnitus treatment device double in latest expansion

7 March 2025 | Research & Development
Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device. Tinnitus, which is commonly known as “ringing in...

Neuromod expands availability of Lenire tinnitus treatment device in Europe with 19 new clinical partnerships

1 October 2025 | Company Profiles
Neuromod Devices, the technology company that specialises in medical devices for tinnitus treatment, has announced 19 new clinical partnerships to expand the availability of the Lenire tinnitus treatment device in Europe. This latest expansion will significantly increase the number of...

Update on CEORL-HNS 2024

28 March 2024
As I write this update, there are less than four months to go to the 7th Congress of European ORL Head and Neck Surgery in Dublin and the excitement is building.

Karl Strom Joins HearingTracker as Editor in Chief

19 May 2022 | Company Profiles, Recruitment & Personnel
HearingTracker has appointed Karl Strom as its new Editor in Chief.

Hearing loss prevention in musicians - violating one rule of physics

3 September 2021 | | ENTA - Audiology - Adult, ENTA - Auditory Implants
Whilst enjoying music, we also need to be mindful of the potential effect of producing music for the musician. Dr Chasin discusses the development of earplugs for the industry with the added bonus of physics for party goers! Hearing protection,...

In conversation with Prof Nobuhiko Isshiki

7 January 2020 | | ENTA - ENT, ENTA - Laryngology / Swallowing / Voice
A 90th birthday is definitely a landmark that should be observed and celebrated. Elisabeth Sjögren interviews this man who has been such a huge influence in the world of laryngology. Nobuhiko and Keiko in the cosmos field. Congratulations on your...

Young ESPO – looking back and looking ahead

3 June 2023
In 2018, after the virtual ESPO Marseille meeting, a new committee of ESPO Juniors was established. Last year, the name was changed to Young ESPO.